Cite
HARVARD Citation
Nemunaitis, J. et al. (n.d.). TG4010 immunotherapy plus chemotherapy as first-line treatment of advanced non small cell lung cancer (NSCLC): Phase IIb results of the TIME trial. Journal for immunotherapy of cancer. p. . [Online].